That HLA-E:NKG2C ligation indeed may play a role in enhanced cytotoxicity of NK, even in an HLA:KIR match scenario, was demonstrated by a significantly increased cytotoxic response towards allogeneic GBM cells engineered to express HLA-E*spG. Here, KIR3DL1 is linked to glioblastoma.